×
A global investment manager specializing in real assets and alternative income, Cohen & Steers has been listed on the New York Stock Exchange since 2004 under ...
CNS Pharmaceuticals a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic ...
Cohen & Steers homepage. We are a leading global investment manager specializing in real assets and alternative income. Learn more.
Cohen & Company is committed to providing superior returns to our shareholders. To that end, we seek to provide you with information to answer any questions ...
Missing: cns | Show results with:cns
People also ask
FAQ · Investor Presentation · RSS · Email Alerts · Tear Sheet · Contacts · RSS News Feed. © 2024 CNS Pharmaceuticals. All Rights Reserved, CNS Pharma.
Investor Relations · Institutional Site ESG Site · EN PT; Search. Company · History and Corporate Profile · Ownership Breakdown · Sustainability · Corporate ...
Investor Relations · ~$10 BILLIONCumulative Shareholder Distributions · +27 PERCENTEarnings per Share Growth · 110 PERCENTTotal Shareholder Return.
Informing Decisions. Improving Health. ; link to financials section. Financial Information. Latest results, presentations, and financial calendar ; link to ...
Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including real estate, preferred securities, ...
Find the latest SEC Filings data for Cohen & Steers Inc Common Stock (CNS) including 10-K and 10-Q forms at Nasdaq.com.